Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 12128092 Lyophilized factor IX formulations

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
August 17, 2020
0
Date of Patent
October 29, 2024
0
Patent Application Number
16995173
0
Patent Citations
‌
US Patent 7790415 Enhancing the circulating half-life of antibody-based fusion proteins
0
‌
US Patent 7862820 Immunoglobulin chimeric monomer-dimer hybrids
0
‌
US Patent 8015841 Cryogenic refrigeration system for lyophilization
0
‌
US Patent 8048848 Long-acting interferons and derivatives thereof and methods thereof
0
‌
US Patent 8367805 Fc variants with altered binding to FcRn
0
‌
US Patent 10588949 Factor IX polypeptide formulations
0
‌
US Patent 8563521 Biological active proteins having increased in vivo and/or in vitro stability
0
‌
US Patent 10772942 Lyophilized factor IX formulations
0
‌
US Patent 7592010 Albumin fusion proteins
0
‌
US Patent 7632921 Site-directed modification of FVIII
0
Patent Inventor Names
Brandon W. Leveille
0
Brian M. Thome
0
Cherie Parkhurst-Lang
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
12128092
0
Patent Primary Examiner
‌
Michael Szperka
0

Find more entities like US Patent 12128092 Lyophilized factor IX formulations

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo